New oral contraceptive, Estrostep
January 1997
Parke-Davis will introduce a new oral contraceptive, Estrostep. It'll be out soon in the U.S...possibly later in Canada.
It's "triphasic"...20 mcg of ethinyl estradiol for 5 days...30 mcg for 7 days...then 35 mcg for the last 9 days. Always a fixed dose of progestin.
Overall, it's comparable to a 30 mcg estrogen pill.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive